Quanterix Corporation Common Stock
QTRX US74766Q1013
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Sriram Vandana CFO |
4.79 USD |
4,150 Bought |
19,879 USD |
12/09/2025 | 12/09/2025 |
| Walt David R O |
6.14 USD |
123,990 Bought |
760,803 USD |
12/06/2025 | 13/06/2025 |
| Walt David R O |
6.23 USD |
36,010 Bought |
224,166 USD |
12/06/2025 | 12/06/2025 |
| Toloue Masoud CEO |
5.42 USD |
45,900 Bought |
248,723 USD |
09/06/2025 | 09/06/2025 |
| Walt David R O |
5.34 USD |
78,131 Bought |
417,220 USD |
06/06/2025 | 09/06/2025 |
| Donnelly William P O |
5.44 USD |
93,113 Bought |
506,348 USD |
06/06/2025 | 06/06/2025 |
| Walt David R O |
5.43 USD |
131,869 Bought |
716,576 USD |
06/06/2025 | 06/06/2025 |
| Walt David R O |
13.29 USD |
47,000 Bought |
624,630 USD |
20/08/2024 | 20/08/2024 |
| Toloue Masoud CEO |
10.90 USD |
19,000 Bought |
207,100 USD |
13/08/2024 | 13/08/2024 |
| Olson Laurie J O |
16.98 USD |
1,500 Sold |
25,470 USD |
14/05/2024 | 14/05/2024 |